Sihuan Pharmaceutical Holdings Group (0460.HK) Earnings Analysis
Sihuan Pharmaceutical Holdings Group (0460.HK) next reports earnings on 2026-09-01. Trailing P/E 39.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 0460.HK next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
0460.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | 0.00946 HKD | n/a | n/a | n/a |
| 2025-08-29 | 0.0122 HKD | n/a | n/a | n/a |
| 2024-08-30 | -0.00387 HKD | n/a | n/a | n/a |
0460.HK valuation and analyst view
| Trailing P/E | 39.62 |
|---|---|
| Trailing EPS | 0.01988 HKD |
| Price / book | 1.20 |
| Dividend yield | 1.21% |
| Market cap | 8.14B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sihuan Pharmaceutical Holdings Group (0460.HK)'s next earnings date?
Sihuan Pharmaceutical Holdings Group is next scheduled to report on 2026-09-01.
Did 0460.HK beat earnings last quarter?
Consensus estimate data was not available for 0460.HK's 2026-03-26 report.
What is 0460.HK's current P/E ratio and EPS?
0460.HK trades at a trailing P/E of 39.62 on trailing EPS of 0.01988256884551847 HKD.
What do analysts rate 0460.HK?
0460.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.